CEO Richard A Md Miller purchases 6,932 shares for $83,453.32 at CRVS amid -54.8% decline from 52-week high and -$13.7M net loss.
Richard A Md Miller, President and CEO of Corvus Pharmaceuticals, executed 2 separate purchases totaling 6,932 shares for $83,453.32 on 2026-05-18, increasing his holdings to 1,195,035 shares. The blended average purchase price of $12.04 falls significantly below the 52-week high of $26.95, with the stock currently trading at $12.19, -54.8% from its 52-week peak and down -21.6% over the past 30 days. The company reported a net loss of $-13,692,000.00 over its most recent fiscal year, and the CEO's purchase occurs in a context of sustained equity decline. While this represents an open-market acquisition by the company's chief executive, the modest scale (+0.6% vs pre-transaction holdings) and the broader operating losses provide limited basis for interpreting this as a strong affirmative signal about near-term prospects.